Thank you, Mr. Chair.
I'll just take a few moments here to talk a little bit about the motion.
I want to start by saying that I'm always happy to hear from those leading the charge when it comes to our COVID-19 response, especially around vaccine strategy. I think that, as a standing committee on health, it's incumbent on us to receive these very important updates from our very capable public servants.
However, I want to raise that once again we find ourselves meeting today, forced by a 106(4) motion, which I understand and, as MP Rempel Garner said, is a useful tool when it comes to pulling together meetings around issues of urgency. I don't think anyone here is denying the fact that we're in the midst of a global pandemic and that we should be hearing from our officials.
To be honest, Mr. Chair, I am mostly frustrated with the fact that, before even asking members to request an update from officials in a collaborative way, the opposition continues to make this what seems to be political and partisan, in order to make it seem as though they are the only ones wanting to hear from the witnesses on the motion. I want to state quite frankly that this is absolutely not the case, and I really want to reiterate that we're happy to receive an update from officials on these very important issues.
Mr. Chair, I take some concern with the fact that we're finding ourselves in a situation where some are seeming to instill fear in Canadians around the vaccine strategy. Our Public Health Agency, quite frankly, is world-renowned. I think we would all agree with that. We have some of the leading experts in the world as our public servants, and we need to trust them.
COVID-19—and everyone knows this—knows no borders, and it knows no political party. COVID-19 is not a partisan issue and frankly, Mr. Chair, I know I'm not the only one who is getting a little tired of its being treated as one by some.
I think that despite the challenges, quite frankly, Canada has and will continue to carefully manage our vaccine supply chain, and I have full trust in our government's commitment to get the vaccines in the arms of Canadians as soon as possible.
Colleagues, we've received another two million doses of Moderna and Pfizer, and we're on track to receive more than 20 million vaccines by the end of June. As we've said before and as I think we would all agree, there needs to be more work done, and we won't stop until all Canadians who wish to be vaccinated get their vaccine. However, all parliamentarians, in my opinion, also have a responsibility to ensure that their constituents and all Canadians know that science and evidence show that our strategy is working.
I want to take my province, for example, in terms of proof that our strategy is working. While I have the floor, Mr. Chair, I'll just take a brief moment to commend the hard work of Nova Scotia public health on our vaccine rollout. Our provincial dashboard has regular updates on the number of vaccines administered to date. Yesterday, for example, Nova Scotia announced that the province had administered its 400,000th dose right here, in my riding of Cape Breton—Canso. As of today, close to 520,000 doses of COVID-19 vaccine have been administered.
Our province has doubled the number of vaccines in less than a month, after celebrating 200,000 doses on April 16, I believe it was, and this week, Mr. Chair, we'll be receiving over 50,000 doses of the mRNA vaccines. The province has reached the vaccine coverage rate of more than 80% of people aged 60 and older. This means that older Nova Scotians are protected against the spread of COVID-19, which is a key element in the Nova Scotia vaccine plan.
Today the province announced that adults between the ages of 35 and 39 are now eligible to book their appointments. This age demographic accounts for approximately 63,000 Nova Scotians.
Clearly, our rollout strategy is working. We know that it is the will of the provinces and territories to listen to the advice of NACI to better understand the best course of action for provincial rollout plans.
Obviously, all provinces and territories are unique and have unique COVID guidelines and strategies, but here in the Atlantic region, we've shown that the role of the federal government in supporting provinces in the rollout has been successful. It's been a true collaboration, in fact.
As I said before, I think it's important that we listen to officials. I think that having experts, professionals and scientists here to explain that our campaign is working is a great way to address the fearmongering and fake news that continues to be spread throughout the country by some. I am sure I can speak for my colleagues on the government side when I say that we welcome the opportunity to ask questions and get real facts on the record.
Again, there appears to be little desire to collaborate among some, but, and with respect to my colleagues here today, here is what I think we could have had. We could have had a collegial discussion on inviting the officials to discuss the topics in the motion. Again, we have no issues with that at all.
I think MP O'Connell was the one who said, at the last Standing Order 106(4) meeting, that we need to be working together on this committee. We need to ensure that any fear and hesitancy that Canadians have around vaccines is managed, and that all Canadians know that our world-class Public Health Agency knows the science and knows the facts, and those facts and science can be trusted. Over the course of many months I thought we were making some progress, but today I do have some doubts on that.
Just before I wrap up, Mr. Chair, I'll remind the committee that we find this 106(4) motion being put out just before the constituency week. I think it was MP Davies who raised this before, which is that, quite frankly, constituency weeks are an important part of our parliamentary responsibilities, as is our work in Ottawa—or at least virtual Ottawa for most of us.
Next week was in no way going to be a break for me or for my staff. With Nova Scotia in another lockdown, my plan was to check in with my constituents. I've been reaching out through my office just to see how they're coping. I have no doubt that we all—everyone here—had planned a busy week ahead. Again, I want to reiterate that I have no issue inviting the officials next week. I'm happy to hear from them.
Here is what we need to improve as a committee, and it's just my opinion. I would really appreciate if, moving forward, we could have some respect for the important work we do during constituency weeks, as well as our work on the Hill, and approach these types of meetings in a collaborative way.
Finally, I've gotten to know each and every one of you and I know that each one of you on the committee want to achieve collaboration, so I believe we can do that.
Thank you, Mr. Chair.